IC
HIMS icon

Ikarian Capital’s Hims & Hers Health HIMS Stock Holding History

Ikarian Capital’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.53M Buy
+188,381
New +$5.06M 0.7% 40

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ikarian Capital's HIMS Position: Q2 2026 in Review

Ikarian Capital opened a new position in Hims & Hers Health (HIMS) in Q2 2026: 188,381 shares worth $6.53M. The stake represents 0.7% of the portfolio and ranks #40 among its holdings.

504 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Ikarian Capital held 188,381 shares of Hims & Hers Health worth $6.53M as of Q2 2026.
  • Hims & Hers Health was a new Ikarian Capital position in Q2 2026.
  • Hims & Hers Health made up 0.7% of Ikarian Capital's portfolio in Q2 2026, its #40 holding.
  • 504 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.